BN Business News
Şirketinizi ekleyin →
Bu çeviri hazırlanıyor. Bu süre içinde İngilizce orijinal sürümü gösteriyoruz.

İş dünyası · 20.05.20241 dk okuma

Prospective Grant of an Exclusive Patent License: T Cell Receptor Fusion Proteins for the Treatment of Cancer

Yerel otomatik çeviri · Kaynağın orijinal dili

Özet

The National Cancer Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the Patents and Patent Applications listed in the Supplementary Information section of this notice to INTcRON LLC ("INTcRON") located in Memphis, Tennessee.

Kaynağın orijinal dili: Federal Register — Health and Human ServicesOrijinal duyuruyu açın →